O’Melveny Worldwide

Ye Sun has extensive experience advising issuers and underwriters on initial public offerings and secondary offerings in the United States and Hong Kong. He also advises large corporations, private equity funds, and financial advisors on M&A and private placement transactions, and on their general corporate matters. He has led the successful execution of a large number of complex, headline-grabbing transactions, and his services are highly sought-after by many issuers and investment banks.

Capital Markets—Hong Kong IPOs

  • Tiantu Capital (1973.HK) in its approximately US$144 million IPO and listing on the Hong Kong Stock Exchange, marking the first-ever listing of a PRC VC firm in Hong Kong
  • CICC, CCB, CMB, CMS and 18 other underwriters in approximately US$150 million IPO of Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) on the Hong Kong Stock Exchange
  • Cryofocus Medtech (Shanghai) Co., Ltd. in its US$27 million IPO and listing on the Hong Kong Stock Exchange
  • Sipai Health Technology Co., Ltd. in its US$23.7 million IPO and listing on the Hong Kong Stock Exchange
  • Jenscare Scientific Co., Ltd. in its US$28.6 million IPO and listing on the Hong Kong Stock Exchange
  • Yonghe Medical Group Co., Ltd. in its US$206 million IPO and listing on the Hong Kong Stock Exchange
  • Shanghai Bio-heart Biological Technology Co., Ltd. in its US$65.3 million IPO and listing on the Hong Kong Stock Exchange
  • Acotec Scientific Holdings Limited in its US$210 million IPO and listing on the Hong Kong Stock Exchange
  • Goldman Sachs, CICC and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
  • Peijia Medical Limited in its US$343 million IPO and listing on the Hong Kong Stock Exchange
  • Honliv Healthcare Management Group Company Limited in its US$42 million IPO and listing on the Hong Kong Stock Exchange
  • Yeahka Limited in its US$212 million IPO and listing on the Hong Kong Stock Exchange
  • Guotai Junan and other underwriters in the US$65 million IPO and listing of Zhongguancun Science-Tech Leasing on the Hong Kong Stock Exchange
  • Fortune Financial Capital, CICC and other underwriters in the US$65.3 million IPO and listing of Zero2IPO Holdings Inc. on the Hong Kong Stock Exchange
  • First Shanghai Capital and other underwriters in the US$70 Million IPO and listing of Chen Lin Education Group on the Hong Kong Stock Exchange
  • Inke Limited in its US$140 million IPO and listing on the Hong Kong Stock Exchange
  • CICC, ICBC International, Macquarie and other underwriters in the US$35 million IPO and listing of Wanka Online Inc. on the Hong Kong Stock Exchange
  • 3SBio Inc. in its US$700 million IPO and listing on the Hong Kong Stock Exchange

Capital Markets—U.S. IPOs

  • Aesthetic Medical International Holdings in its US$34.5 million IPO and listing on NASDAQ
  • Goldman Sachs, Deutsche Bank and Citigroup and other underwriters in the US$44 million IPO and listing of Pintec Technology Holdings Limited on NASDAQ
  • Goldman Sachs, Morgan Stanley, J.P. Morgan and China Renaissance and other underwriters in the US$180 million IPO and listing of Jianpu Technology Inc. on NASDAQ
  • Zhaopin Limited in its US$75.7 million IPO and listing on the NYSE
  • Yirendai Limited in its US$75.0 million IPO and listing on NASDAQ

Capital Markets—Others

  • J.P. Morgan, BofA Securities, CICC, Haitong International and other underwriters in the US$1.92 billion U.S.-Hong Kong dual listing of GDS Holdings Limited
  • Bitauto Holdings Limited, in the US$1.6 billion PIPE investments in Bitauto Holdings Limited by JD.com, Inc. and Tencent Holdings Limited
  • The Carlyle Group in the US$700 million PIPE investments in SouFun Holdings Limited by The Carlyle Group, IDG Capital Partners and the management of SouFun Holdings Limited
  • Morgan Stanley, Credit Suisse, BofA Merrill Lynch and Jefferies and other underwriters in the US$362 million SEC-registered follow-on offering by China Biologic Products, Inc.
  • Selling shareholders in the US$203 million SEC-registered follow-on offering by I-Mab
  • Various major shareholders of U.S. and/or Hong Kong-listed companies in their respective equity collar, margin loan and other derivatives transactions
  • China Petrochemical Corporation in its $4.8 billion and €1.5 billion senior notes offering
  • China Petrochemical Corporation in its $6.0 billion senior notes offering
  • China Petrochemical Corporation in its $2.75 billion and €550 million senior notes offering

Mergers & Acquisitions

  • Musical.ly and its founders in the US$1.0 billion sale of musical.ly to Bytedance Ltd.
  • Founders of Zhenai.com in the US$310 million sale of shares of Zhenai.com to PAG
  • Eldorado Gold Corporation in its US$600 million sale of gold mines to an affiliate of Yintai Resources Co. Ltd.
  • Eldorado Gold Corporation in its US$300 million sale of a gold mine to an affiliate of China National Gold Group
  • China Logistics Property Holdings Co., Ltd. (CNLP) in its establishment of a joint venture with investment funds managed by Jones Lang LaSalle Inc.
  • VMware, Inc. in its establishment of a joint venture with Sugon Information Industry Co., Ltd.
  • Lattice Power Corporation in its acquisition by the Hong Kong-listed Shunfeng International Clean Energy Limited

Private Equity Investments

  • Beijing Automotive Industry Corporation (BAIC) in its investment in Atieva Inc.
  • Morgan Stanley Private Equity Asia in its private equity investment in Noah Education Holdings Ltd.
  • Particle Inc. in its Series D financing and strategic collaboration with OPPO, Phoenix New Media, Xiaomi and Shunwei
  • Lattice Power Corporation in its Series D financing
  • Leyou, Inc. in its share repurchase transactions with shareholders including investment funds managed by The Carlyle Group and AsiaVest Partners

Going-Private Transactions

  • The buyer consortium in the going-private transaction of the NASDAQ-listed Zhongpin Inc.
  • The buyer consortium in the going-private transaction of the NASDAQ-listed Yongye International Inc.
  • The buyer consortium in the going-private transaction of the NASDAQ-listed JA Solar Holdings Co., Ltd.
  • The buyer consortium in the going-private transaction of the NYSE-listed Noah Education Holdings Ltd.
  • The buyer consortium in the going-private transaction of the NYSE-listed Camelot Information Systems Inc.
  • The buyer consortium in the going-private transaction of the NYSE-listed Mindray Medical International Limited
  • The buyer consortium in the going-private transaction of the NYSE-listed Xueda Education Group
  • The buyer consortium in the going-private transaction of the OTCBB-quoted Sino Gas International Holdings, Inc.
  • Members of the buyer consortium in the going-private transaction of the NASDAQ-listed AsiaInfo-Linkage, Inc.
  • Members of the buyer consortium in the going-private transaction of the NASDAQ-listed 3SBio Inc.
  • Members of the buyer consortium in the going-private transaction of the NASDAQ-listed Le Gaga Holdings Limited
  • Members of the buyer consortium in the going-private transaction of the NASDAQ-listed MEMSIC, Inc.
  • The special committee of the board of directors in the going-private transaction of the NASDAQ-listed Sungy Mobile Limited

Compliance Matters

  • Various companies including China Petroleum & Chemical Corporation, Sinopec Shanghai Petrochemical Company Limited, Huaneng Power International Inc., Peijia Medical, Acotec Scientific Holdings Limited, BitAuto Holdings Limited, Ozner Water International Holding Ltd, China Logistics Property Holdings Co., Ltd., Inke Limited, and Aesthetic Medical International Holdings in their U.S. and/or Hong Kong securities law compliance matters

Languages

  • English
  • Mandarin

Admissions

  • New York

Education

  • Cornell Law School, J.D., 2011
  • Renmin University of China Law School, LL.B., 2008

Related Regions